Century Therapeutics(IPSC)
Focus: Century Therapeutics is a public biotech company developing induced pluripotent stem cell (iPSC)-based cell therapies, positioned at the forefront of regenerative medicine. The company is early-stage with minimal revenue but significant R&D investment.
Profile data last refreshed 16h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
5+3 this month
Stable — net +3 jobs in 30d
3 added, 0 removed. Backfill posture.
Should You Work at Century Therapeutics?
AI assessmentCentury is a high-risk, high-reward pre-revenue biotech bet suitable only for scientists/operators comfortable with platform-stage execution risk and potential cash constraints; not recommended for those seeking stability or rapid career progression.
Why Work Here
- Work on cutting-edge iPSC platform technology with potential to transform cell therapy across oncology, autoimmune, and metabolic diseases
Data completeness
6/9 — Partial
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$7M
Key Products
LOE Approaching
Legacy NDA product with loss-of-exclusivity approaching; minimal strategic value to company's iPSC-focused pipeline.
Help build intelligence for Century Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.